Advertisement

FDA Panel Recommends HIV Prevention Drug

Last night, an FDA advisory committee voted 19–3 to endorse the drug Truvada for use in controlling HIV infection among men who have sex with men, including preventive use by men who are partnered with someone who is HIV-positive. This would be the first drug ever marketed for HIV prevention, a process known as pre-exposure prophylaxis (PrEP). FDA regulators still have to give final consideration to the recommendation before Truvada can be distributed.

Advertisement